francesco paolo perelli (@fpperelli) profile picture
Joined February 2022
Photo by francesco paolo perelli (@fpperelli)Photo by francesco paolo perelli (@fpperelli)Photo by francesco paolo perelli (@fpperelli)Photo by francesco paolo perelli (@fpperelli)Photo by francesco paolo perelli (@fpperelli)Photo by francesco paolo perelli (@fpperelli)Photo by francesco paolo perelli (@fpperelli)Photo by francesco paolo perelli (@fpperelli)Photo by francesco paolo perelli (@fpperelli)Photo by francesco paolo perelli (@fpperelli)
📢 Long-term efficacy and safety of #LAAC vs. oral anticoagulation in atrial fibrillation: a meta-analysis of randomised controlled trials 👉 ow.ly/11Tw50Zu8iA @EuropaceEiC @GiulioConteMD @Dominik_Linz @FraSantoroMD @AndyZhangMD @marcovitoloMD @DavideMei93 #Europace #arrhythmias #AF
7
64
5
153
19,808
Aspirin vs clopidogrel in chronic coronary syndromes: a meta-analysis of ethnic differences. Discover more in #EHJ 👉 ow.ly/xgN550Z4Y1c @RoccoMontone @ehj_ed
26
3
73
27,313
francesco paolo perelli retweeted
Dantrolene shows promise as a safe, feasible strategy to prevent doxorubicin-induced #cardiomyopathy (DIC). Already used for malignant #hyperthermia, it may be repurposed for DIC prevention. jacc.org/doi/10.1016/j.jacca… #JACCCardioOnc #cvPrev #CardioOnc
3
18
1
62
7,378
Coronary microvascular dysfunction as an initial clue to the diagnosis of light-chain amyloidosis ow.ly/B9Kk50YgtCO #EHJCaseReports @Phiso_de @TJ_Yeo @aayshacader @BoldiKovacsMD @SukritiBanthiya @ANazmiCalik @O_Azizy_MD @saramoscatelli7 @EHJCREiC #CardioX
27
1
77
5,697
francesco paolo perelli retweeted
❤️ 🧲CMR T2 mapping predicts survival in AL amyloidosis—even after strong treatment response. Myocardial edema flags hidden risk beyond biomarkers. pdf 👉 journalofcmr.com/article/S10… Dr. Yining Wang explains below 👇 #WhyCMR
3
6
395
francesco paolo perelli retweeted
The authors present the largest series of #TTVR after T-TEER with electrosurgical leaflet modification in a subset of patients. At 30 days, TR severity was markedly reduced, and substantial symptom alleviation occurred. jacc.org/doi/10.1016/j.jcin.… #JACCINT #vhdTR #TEER @jtsaxon
2
12
1
41
23,435
francesco paolo perelli retweeted
New in #JACCINT: 1-year results from the #CLASPIID trial show #MTEER benefits patients with degenerative MR across all cardiac damage stages 💪 Significant MR & #QoL improvements 🌟 low adverse events ⚡ and low mortality jacc.org/doi/10.1016/j.jcin.… #vhdMR #TEER @AbdullahAlabcha
1
14
1
42
6,251
francesco paolo perelli retweeted
2025 ACC Expert Consensus Decision Pathway on Evaluation & Management of Tricuspid Regurgitation @JACCJournals @ACCinTouch #TR #CardioX jacc.org/doi/10.1016/j.jacc.…
1
55
167
10,182
Atrial fibrillation ablation in hypertrophic obstructive cardiomyopathy – should we propose these patients to intervention? More on the potential outcomes in ow.ly/x9oM50X7Ify #EHJQCCO #AFib #HCM #PVI @cpgale3 @diogoasantosfer @m_piepoli
2
31
2
88
13,359
Today, I had the pleasure of discussing atrial fibrillation in patients with hypertrophic cardiomyopathy and cardiac amyloidosis. I would like to thank my mentor for this opportunity and for his continued support. @CrottiLia
2
38
francesco paolo perelli retweeted
Mitochondrial cardiomyopathies This review discusses comprehensive overview of the pathophysiology, clinical features, diagnostic approaches, and treatment options for mitochondrial #CMP academic.oup.com/eurheartj/a… #CardioEd @ehj_ed @ESC_Journals
8
42
2,542